Gecina published its H1 16 figures with GRI at €298m, up 8.2% yoy, supported by T1&B and PSA, and flat on an lfl basis, with indexation remaining low (+0.3%) and renewals and renegotiations in offices impacting organic growth. Triple net NAV stood at €128.6, gaining 4.8%, and the group share EPS gained 15.4% yoy to €3.16. The group’s pipeline now stands at 30% of the total portfolio (excluding Gecimed) or €3.6bn (o/w 60% controlled), and its financial position is
22 Jul 2016
Positive H1 figures and the battle for FDP goes on
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Positive H1 figures and the battle for FDP goes on
Gecina SA (GFC:WBO) | 0 0 2.8% | Mkt Cap: 11,480m
- Published:
22 Jul 2016 -
Author:
Alda Kule Dale -
Pages:
3
Gecina published its H1 16 figures with GRI at €298m, up 8.2% yoy, supported by T1&B and PSA, and flat on an lfl basis, with indexation remaining low (+0.3%) and renewals and renegotiations in offices impacting organic growth. Triple net NAV stood at €128.6, gaining 4.8%, and the group share EPS gained 15.4% yoy to €3.16. The group’s pipeline now stands at 30% of the total portfolio (excluding Gecimed) or €3.6bn (o/w 60% controlled), and its financial position is